Overexpression of SERBP1 (Plasminogen activator inhibitor 1 RNA binding protein) in human breast cancer is correlated with favourable prognosis
© Serce et al.; licensee BioMed Central Ltd. 2012
Received: 9 September 2012
Accepted: 6 December 2012
Published: 13 December 2012
Open Peer Review reports
Pre-publication versions of this article and author comments to reviewers are available by contacting email@example.com.
|9 Sep 2012||Submitted||Original manuscript|
|Resubmission - Version 2|
|Submitted||Manuscript version 2|
|15 Sep 2012||Reviewed||Reviewer Report - Hiroko Yamashita|
|28 Sep 2012||Reviewed||Reviewer Report - Yiannis Drosos|
|14 Nov 2012||Author responded||Author comments - Nuran Bektas Serce|
|Resubmission - Version 3|
|14 Nov 2012||Submitted||Manuscript version 3|
|19 Nov 2012||Reviewed||Reviewer Report - Hiroko Yamashita|
|29 Nov 2012||Reviewed||Reviewer Report - Yiannis Drosos|
|3 Dec 2012||Author responded||Author comments - Nuran Bektas Serce|
|Resubmission - Version 4|
|3 Dec 2012||Submitted||Manuscript version 4|
|6 Dec 2012||Editorially accepted|
|13 Dec 2012||Article published||10.1186/1471-2407-12-597|
How does Open Peer Review work?
Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting firstname.lastname@example.org. All previous versions of the manuscript and all author responses to the reviewers are also available.
You can find further information about the peer review system here.